Monash IVF Group Limited

ASX:MVF Stock Report

Market Cap: AU$481.2m

Monash IVF Group Past Earnings Performance

Past criteria checks 0/6

Monash IVF Group's earnings have been declining at an average annual rate of -5.9%, while the Healthcare industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 11% per year.

Key information

-5.9%

Earnings growth rate

-16.6%

EPS growth rate

Healthcare Industry Growth2.4%
Revenue growth rate11.0%
Return on equity-2.4%
Net Margin-2.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Aug 25
Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Feb 26
Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Aug 28
Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Nov 19
Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04
Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29
Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14
Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06
Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25
Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13
Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14
Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04
Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26
Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15
Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03
A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22
We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10
Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28
Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17
What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06
Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24
Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Revenue & Expenses Breakdown

How Monash IVF Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ASX:MVF Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24255-7210
31 Mar 242469200
31 Dec 2323624200
30 Sep 2322523190
30 Jun 2321422180
31 Mar 2320419180
31 Dec 2219517180
30 Sep 2219318180
30 Jun 2219218180
31 Mar 2219321180
31 Dec 2119423170
30 Sep 2118924160
30 Jun 2118425140
31 Mar 2117122130
31 Dec 2015918130
30 Sep 2015215120
30 Jun 2014512120
31 Mar 2014915120
31 Dec 1915218120
30 Sep 1915219120
30 Jun 1915220110
31 Mar 1915119140
31 Dec 1815119170
30 Sep 1815120170
30 Jun 1815121170
31 Mar 1815224170
31 Dec 1715326160
30 Sep 1715428160
30 Jun 1715530160
31 Mar 1715630160
31 Dec 1615630150
30 Sep 1615629160
30 Jun 1615729160
31 Mar 1615027130
31 Dec 151442490
30 Sep 151342390
30 Jun 151252190
31 Mar 151211580
31 Dec 14117880
30 Sep 14115580
30 Jun 14114390
31 Mar 14110240
31 Dec 13106000

Quality Earnings: MVF is currently unprofitable.

Growing Profit Margin: MVF is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MVF is unprofitable, and losses have increased over the past 5 years at a rate of 5.9% per year.

Accelerating Growth: Unable to compare MVF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MVF is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-25.4%).

Return on Equity

High ROE: MVF has a negative Return on Equity (-2.41%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Monash IVF Group Limited is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Tara SperanzaBell Potter
Martyn JacobsBell Potter